Sign up to save your podcasts
Or
Share #027 $ZBIO IPO Meltdown Investors Left in the Dark?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#027 $ZBIO IPO Meltdown Investors Left in the Dark?
Zenas BioPharma $ZBIO dazzled Wall Street with its biotech promise—but did it deceive investors from the start? This week on Bulls and Betrayal, Anna and Nate unravel the class action lawsuit claiming $ZBIO overstated its financial runway and misled buyers during its 2024 IPO. If you're a retail investor, legal aficionado, or just love a juicy Wall Street exposé, this one’s for you. Expect sharp commentary, deep dives, and accountability served cold.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.
🎧 Subscribe and follow @bullsandbetrayal | Visit ZLK.com for more.
Keywords:
$ZBIO Zenas BioPharma IPO lawsuit biotech stock fraud class action securities underwriter due diligence shareholder rights Wall Street deception
View all episodes
By bullsandbetrayalZenas BioPharma $ZBIO dazzled Wall Street with its biotech promise—but did it deceive investors from the start? This week on Bulls and Betrayal, Anna and Nate unravel the class action lawsuit claiming $ZBIO overstated its financial runway and misled buyers during its 2024 IPO. If you're a retail investor, legal aficionado, or just love a juicy Wall Street exposé, this one’s for you. Expect sharp commentary, deep dives, and accountability served cold.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.
🎧 Subscribe and follow @bullsandbetrayal | Visit ZLK.com for more.
Keywords:
$ZBIO Zenas BioPharma IPO lawsuit biotech stock fraud class action securities underwriter due diligence shareholder rights Wall Street deception